Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT01966445 |
Title | Dose Escalation Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of GSK2849330 in Subjects With Advanced Her3-Positive Solid Tumors |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | GlaxoSmithKline |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA | NLD | AUS |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
GSK Investigational Site | Aurora | Colorado | 80045 | United States | Details | |
GSK Investigational Site | New York | New York | 10065 | United States | Details | |
GSK Investigational Site | Salt Lake City | Utah | 84112 | United States | Details | |
GSK Investigational Site | Heidelberg | Victoria | 3084 | Australia | Details | |
GSK Investigational Site | Melbourne | Victoria | 3004 | Australia | Details | |
GSK Investigational Site | Nedlands | Western Australia | 6009 | Australia | Details | |
GSK Investigational Site | Amsterdam | 1066 CX | Netherlands | Details | ||
GSK Investigational Site | Amsterdam | 1066 C | Netherlands | Details | ||
GSK Investigational Site | Groningen | 9713 GZ | Netherlands | Details | ||
GSK Investigational Site | Groningen | 9713 G | Netherlands | Details | ||
GSK Investigational Site | Nijmegen | 6525 GA | Netherlands | Details | ||
GSK Investigational Site | Nijmegen | 6525 G | Netherlands | Details | ||
GSK Investigational Site | Rotterdam | 3075 EA | Netherlands | Details | ||
GSK Investigational Site | Rotterdam | 3075 E | Netherlands | Details |